AB-x Synthetic Cannabinoids Research Dashboard
Double-blind human trials
Clinical human trials
What am I missing as a non-subscriber?
To see a full dashboard with study details and filtering, go to our DEMO page.
As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.
CannaKeys has 4 studies associated with AB-x Synthetic Cannabinoids.
Here is a small sampling of AB-x Synthetic Cannabinoids studies by title:
- Acute effects of 4-EA-NBOMe, 3, 4-DCMP, LY-2183240 and AB-CHFUPYCA on the excitability of rat cortical primary cultured neurons
- Phenotype-Based Screening of Synthetic Cannabinoids in a Dravet Syndrome Zebrafish Model
- Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA
Components of the AB-x Synthetic Cannabinoids Research Dashboard
- Top medical conditions associated with AB-x Synthetic Cannabinoids
- Proven effects in clinical trials for AB-x Synthetic Cannabinoids
- Receptors associated with AB-x Synthetic Cannabinoids
- Individual study details for AB-x Synthetic Cannabinoids
Ready to become a subscriber? Go to our PRICING page.
Members can filter by the following criteria:
- Study Type
- Organ Systems
- Study Result
- Year of Publication
Overview - AB-x Synthetic Cannabinoids
Description of AB-x Synthetic Cannabinoids
The AB-x class of synthetic cannabinoids is small and two of its main member are AB-FUBINACA and AB-CHFUPYCA both of which were first detected in illegal recreational products in Japan.
AB Family Synthetic Cannabinoids
AB-FUBINACA (numerous supplier-based synonyms plus a great number of analogues)
Molecular Formula: C20H21FN4O2
IUPAC name: N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]indazole-3-carboxamide
Molecular Formula: C22H29FN4O2
IUPAC name: N-(1-amino-3-methyl-1-oxobutan-2-yl)-2-(cyclohexylmethyl)-5-(4-fluorophenyl)pyrazole-3-carboxamide
AB-x Synthetic Cannabinoids Properties and Effects
AB-x Synthetic Cannabinoids Receptor Binding
Endocannabinoid System (ECS) and AB-FUBINACA:
• CB1 full agonist (S. Banister et al., 2015)
• CB2 full agonist (S. Banister et al., 2015)
Receptor binding data of AB-CHFUPYCA is awaiting further scientific investigation.
Disclaimers: Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.
Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.